Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M2 | ||
Ligand | BDBM50522818 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888527 (CHEMBL4390204) | ||
Ki | 0.690000±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M2 | |||
Name: | Muscarinic acetylcholine receptor M2 | ||
Synonyms: | ACM2_HUMAN | CHRM2 | Cholinergic, muscarinic M2 | Muscarinic acetylcholine receptor M2 and M4 | Muscarinic acetylcholine receptor M2 and M5 | RecName: Full=Muscarinic acetylcholine receptor M2 | ||
Type: | GPCR | ||
Mol. Mass.: | 51730.61 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P08172 | ||
Residue: | 466 | ||
Sequence: |
| ||
BDBM50522818 | |||
n/a | |||
Name | BDBM50522818 | ||
Synonyms: | CHEMBL4436930 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H33BrFNO3 | ||
Mol. Mass. | 554.49 | ||
SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCCc3cccc(F)c3)CCC1CC2)(c1ccccc1)c1ccccc1 |(60.41,-49.31,;51.01,-51.16,;52.35,-51.94,;53.68,-52.7,;53.69,-54.24,;55.02,-51.93,;56.35,-52.7,;57.68,-51.92,;59,-52.7,;60.34,-51.93,;61.67,-52.7,;63.01,-51.93,;64.34,-52.71,;65.67,-51.94,;67,-52.7,;67,-54.25,;65.66,-55.02,;65.66,-56.56,;64.33,-54.25,;59.01,-54.24,;57.68,-55,;56.35,-54.24,;57.84,-54.03,;57.49,-52.98,;52.34,-50.4,;53.67,-49.63,;53.67,-48.09,;52.33,-47.32,;51,-48.1,;51.01,-49.64,;51.02,-52.71,;49.68,-51.94,;48.35,-52.71,;48.36,-54.25,;49.7,-55.02,;51.03,-54.24,)| | ||
Structure |